Medicinal Interactions

Even at 25mg, Sildenafil Citrate has clinically significant drug interactions. Patients should provide their prescriber with a complete medication list — including over-the-counter drugs, supplements, and herbal products — before using this cenforce pill.

• Organic Nitrates (e.g., glyceryl trinitrate, isosorbide mononitrate, isosorbide dinitrate): Absolute contraindication. Sildenafil potentiates the vasodilatory effect of nitrates, causing a sudden, severe reduction in blood pressure that may be fatal. This interaction applies at all doses, including 25mg. Men who use nitrates for angina or heart failure must not take any Sildenafil product.
• Riociguat (soluble guanylate cyclase stimulator): Co-administration is contraindicated. Both drugs augment the cGMP pathway and their combination causes severe hypotension.
• Alpha-Adrenergic Blockers (e.g., doxazosin, tamsulosin, terazosin): Additive blood pressure-lowering effect. When co-administration is clinically necessary, Sildenafil should be initiated at the lowest dose (25mg) and sufficient time should elapse after the alpha-blocker dose before Sildenafil is taken, as directed by a physician.
• Strong CYP3A4 Inhibitors (e.g., ritonavir, ketoconazole, itraconazole, clarithromycin): These drugs significantly increase Sildenafil plasma concentrations by inhibiting its hepatic metabolism. The prescribing information for Sildenafil recommends a maximum dose of 25mg every 48 hours when used with strong CYP3A4 inhibitors.
• Moderate CYP3A4 Inhibitors (e.g., erythromycin, saquinavir, amprenavir): May moderately increase Sildenafil exposure. Physicians may recommend the 25mg dose as a precaution in these cases.
• CYP3A4 Inducers (e.g., rifampicin, carbamazepine, phenytoin, St. John’s Wort): These drugs accelerate Sildenafil metabolism, potentially reducing its plasma concentration and therapeutic effect. Men on these medications may find the cenforce pill less effective.
• Other PDE-5 Inhibitors: Concurrent use of any two PDE-5 inhibitors is not recommended due to additive pharmacodynamic effects and increased adverse event risk.
• Antihypertensive Agents: Sildenafil has a mild blood pressure-lowering effect. In combination with antihypertensives, this can lead to symptomatic hypotension — particularly relevant in older patients or those on multiple blood pressure medications.

Disease Interactions

The following conditions are either contraindications or require careful risk-benefit assessment by a physician before prescribing Sildenafil Citrate at any dose:

• Cardiovascular Disease: Men with unstable angina, recent myocardial infarction (within 90 days), recent stroke (within 6 months), or serious ventricular arrhythmia should not use Sildenafil without explicit cardiological clearance. Sexual activity itself is associated with cardiovascular demand equivalent to mild-to-moderate physical exertion.
• Hypotension (resting BP below 90/50 mmHg): Sildenafil is contraindicated in this setting due to the risk of further blood pressure reduction.
• Uncontrolled Hypertension (resting BP above 170/110 mmHg): Use is not recommended until blood pressure is adequately controlled.
• Hepatic Impairment: Moderate-to-severe liver disease reduces Sildenafil clearance, increasing plasma concentration. A 25mg starting dose is recommended by prescribing guidelines for men with hepatic impairment; doses above 25mg require medical supervision.
• Renal Impairment: Severe kidney disease (creatinine clearance below 30 mL/min) leads to increased Sildenafil AUC. A starting dose of 25mg is advised in clinical guidelines for this population.
• Retinitis Pigmentosa: A hereditary retinal dystrophy involving a related phosphodiesterase (PDE-6). Sildenafil’s mild inhibition of PDE-6 may theoretically worsen this condition. Use with caution and ophthalmological review is advisable.
• Anatomical Penile Deformity (e.g., Peyronie’s Disease): Associated with increased priapism risk. Caution is advised.
• Conditions Predisposing to Priapism (e.g., sickle cell anemia, multiple myeloma, leukemia): These conditions independently increase the risk of priapism; Sildenafil may compound this risk.

Food Interactions

• Alcohol: Sildenafil and alcohol both cause vasodilation and blood pressure reduction. Co-ingestion increases the risk of symptomatic hypotension — including dizziness, lightheadedness, and fainting. At 25mg, the combined effect is less severe than at higher doses, but avoidance of significant alcohol intake is still recommended on the day of use.
• Grapefruit and Grapefruit Juice: Inhibits intestinal CYP3A4, leading to increased Sildenafil bioavailability and potentially higher plasma concentrations than intended. Patients should avoid grapefruit products on days they take Cenforce 25 Mg.
• High-Fat Meals: A high-fat meal delays gastric emptying and slows Sildenafil absorption, reducing the rate — though not the extent — of drug absorption. The clinical consequence is a delayed onset of action. A light meal or fasting is preferable for predictable onset timing.

Precautions

The following precautions apply to Cenforce 25 Mg. They are consistent with the standard prescribing information for Sildenafil Citrate and reflect guidance from regulatory bodies including the US FDA:

• Prescription Requirement: Sildenafil Citrate is a prescription medication in the United States. Patients should obtain a valid prescription from a licensed healthcare provider before ordering cenforce online or using this product.
• Not for Use in Women or Minors: Cenforce 25 Mg is indicated exclusively for adult men (18 years and older). It is not approved for use in women or individuals under 18.
• Cardiovascular Risk Assessment: Before initiating treatment, physicians typically assess whether a patient’s cardiovascular status allows the additional physical demand associated with sexual activity. This evaluation is part of responsible prescribing.
• Single Dose Per Day: No more than one tablet of Cenforce 25 Mg should be taken in any 24-hour period. Exceeding this does not improve efficacy and increases adverse event risk.
• Priapism Awareness: All patients should be advised that if an erection lasts more than 4 hours, they must seek emergency medical treatment immediately to prevent irreversible penile injury.
• Vision and Hearing: Patients who experience sudden vision or hearing changes after taking Cenforce 25 Mg should stop use and seek medical evaluation promptly. This may be a sign of rare but serious adverse events.
• Driving and Machinery: Sildenafil may cause dizziness and visual disturbances. Patients should exercise caution when driving or operating machinery, particularly until they understand how their body responds to the medication.
• No STI Protection: This cenforce pill offers no protection against sexually transmitted infections, including HIV/AIDS.
• Storage: Store at room temperature below 30°C. Keep away from moisture, direct light, and out of reach of children. Do not use past the expiry date printed on the packaging.
• Inform All Treating Physicians: Patients should disclose Sildenafil use to all treating clinicians — including dentists and surgeons — as it may affect anesthetic and procedural decisions.